Die 8. Version der TNM-Klassifikation – Fluch oder Segen für das Oropharynxkarzinom?

The 8th edition of the TNM staging system—a curse or a blessing for oropharyngeal carcinoma?

HNO volume 69, pages89–94(2021)Cite this article

Zusammenfassung

Zu Beginn des Jahres 2017 wurde die 8. Version der TNM-Klassifikation vorgestellt. Für das Oropharynxkarzinom bedeutete dies einen Paradigmenwechsel, da eine Trennung der Klassifikation in Abhängigkeit zur Assoziation mit einer Humanen-Papillomvirus-Koinfektion (HPV) hergestellt wurde. Unter Berücksichtigung der Literatur soll hier eine Übersicht über die Besonderheiten HPV-assoziierter Karzinome, die Neuerungen der TNM-Klassifikationen sowie die bestehenden Diskussionspunkte gegeben werden. Durch die Revision wurde die prognostische Aussagekraft der TNM-Klassifikation verbessert. Es bestehen jedoch weiterhin tumor- und patientenabhängige Einflussfaktoren, die bei der Erstellung von zukünftigen Versionen berücksichtigt werden müssen.

Abstract

At the beginning of 2017, the 8th edition of the TNM classification was presented. For oropharyngeal carcinoma, this was accompanied by a paradigm shift, as a separation of the classification depending on the association with human papillomavirus (HPV) status has been established. By considering the literature, this paper provides an overview of the characteristics of HPV-associated carcinomas, the new features of the TNM classification, and the existing points of discussion. The revision has improved the prognostic significance of the TNM classification; however, there are still tumor- and patient-dependent influencing factors that must be considered for future versions.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

US$ 39.95

Tax calculation will be finalised during checkout.

Literatur

  1. 1.

    Amin MB, Edge SB, Greene FL et al (Hrsg) (2017) AJCC cancer staging manual, 8. Aufl. Springer, New York

    Google Scholar 

  2. 2.

    Vokes EE, Agrawal N, Seiwert TY (2015) HPV-associated head and neck cancer. j Natl Cancer Inst 107(12):djv344

    Article  Google Scholar 

  3. 3.

    Würdemann N, Wagner S, Sharma SJ, Prigge ES, Reuschenbach M, Gattenlöhner S, Klussmann JP, Wittekindt C (2017) Prognostic impact of AJCC/UICC 8th edition new staging rules in oropharyngeal squamous cell carcinoma. Front Oncol 7:129

    Article  Google Scholar 

  4. 4.

    Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tân PF, Westra WH, Chung CH, Jordan RC, Lu C, Kim H, Axelrod R, Silverman CC, Redmond KP, Gillison ML (2010) Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363(1):24–35

    CAS  Article  Google Scholar 

  5. 5.

    O’Sullivan B, Huang SH, Su J, Garden AS, Sturgis EM, Dahlstrom K, Lee N, Riaz N, Pei X, Koyfman SA, Adelstein D, Burkey BB, Friborg J, Kristensen CA, Gothelf AB, Hoebers F, Kremer B, Speel EJ, Bowles DW, Raben D, Karam SD, Yu E, Xu W (2016) Development and validation of a staging system for HPV-related oropharyngeal cancer by the international collaboration on oropharyngeal cancer network for staging (ICON-S): a multicentre cohort study. Lancet Oncol 17:440–451

    Article  Google Scholar 

  6. 6.

    Zhan KY, Eskander A, Kang SY, Old MO, Ozer E, Agrawal AA, Carrau RL, Rocco JW, Teknos TN (2017) Appraisal of the AJCC 8th edition pathologic staging modifications for HPV-positive oropharyngeal cancer, a study of the national cancer data base. Oral Oncol 73:152–159

    Article  Google Scholar 

  7. 7.

    Mizumachi T, Homma A, Sakashita T, Kano S, Hatakeyama H, Fukuda S (2017) Confirmation of the eighth edition of the AJCC/UICC TNM staging system for HPV-mediated oropharyngeal cancer in Japan. Int J Clin Oncol 22(4):682–689

    Article  Google Scholar 

  8. 8.

    Smith EM, Ritchie JM, Summersgill KF, Klussmann JP, Lee JH, Wang D, Haugen TH, Turek LP (2004) Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers. Int J Cancer 108(5):766–772

    CAS  Article  Google Scholar 

  9. 9.

    Weatherspoon DJ, Chattopadhyay A, Boroumand S, Garcia I (2015) Oral cavity and oropharyngeal cancer incidence trends and disparities in the United States: 2000–2010. Cancer Epidemiol 39(4):497–504

    Article  Google Scholar 

  10. 10.

    Fakhry C, Westra WH, Wang SJ, van Zante A, Zhang Y, Rettig E, Yin LX, Ryan WR, Ha PK, Wentz A, Koch W, Richmon JD, Eisele DW, D’Souza G (2017) The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer. Cancer 123(9):1566–1575

    CAS  Article  Google Scholar 

  11. 11.

    Posner MR, Lorch JH, Goloubeva O, Tan M, Schumaker LM, Sarlis NJ, Haddad RI, Cullen KJ (2011) Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial. Ann Oncol 22(5):1071–1077

    CAS  Article  Google Scholar 

  12. 12.

    Rosenthal DI, Harari PM, Giralt J, Bell D, Raben D, Liu J, Schulten J, Ang KK, Bonner JA (2016) Association of human papillomavirus and p16 status with outcomes in the IMCL-9815 phase III registration trial for patients with locoregionally advanced oropharyngeal squamous cell carcinoma of the head and neck treated with radiotherapy with or without cetuximab. J Clin Oncol 34(12):1300–1308

    CAS  Article  Google Scholar 

  13. 13.

    Rischin D, Young RJ, Fisher R, Fox SB, Le QT, Peters LJ, Solomon B, Choi J, O’Sullivan B, Kenny LM, McArthur GA (2010) Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial. J Clin Oncol 28(27):4142–4148

    CAS  Article  Google Scholar 

  14. 14.

    Fakhry C, Zhang Q, Nguyen-Tan PF, Rosenthal D, El-Naggar A, Garden AS, Soulieres D, Trotti A, Avizonis V, Ridge JA, Harris J, Le QT, Gillison M (2014) Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma. J Clin Oncol 32(30):3365–3373

    Article  Google Scholar 

  15. 15.

    El-Naggar AK, Westra WH (2012) p16 expression as a surrogate marker for HPV-related oropharyngeal carcinoma: a guide for interpretative relevance and consistency. Head Neck 34(4):459–461

    Article  Google Scholar 

  16. 16.

    Lydiatt WM, Patel SG, O’Sullivan B, Brandwein MS, Ridge JA, Migliacci JC, Loomis AM, Shah JP (2017) Head and neck cancers-major changes in the American joint committee on cancer eighth edition cancer staging manual. CA Cancer J Clin 67(2):122–137

    Article  Google Scholar 

  17. 17.

    Sinha P, Kallogjeri D, Gay H, Thorstad WL, Lewis JS Jr, Chernock R, Nussenbaum B, Haughey BH (2015) High metastatic node number, not extracapsular spread or N‑classification is a node-related prognosticator in transorally-resected, neck-dissected p16-positive oropharynx cancer. Oral Oncol 51(5):514–520

    Article  Google Scholar 

  18. 18.

    Porceddu SV, Milne R, Brown E, Bernard A, Rahbari R, Cartmill B, Foote M, McGrath M, Coward J, Panizza B (2017) Validation of the ICON‑S staging for HPV-associated oropharyngeal carcinoma using a pre-defined treatment policy. Oral Oncol 66:81–86

    Article  Google Scholar 

  19. 19.

    Prigge ES, Arbyn M, von Knebel Doeberitz M, Reuschenbach M (2017) Diagnostic accuracy of p16INK4a immunohistochemistry in oropharyngeal squamous cell carcinomas: a systematic review and meta-analysis. Int J Cancer 140(5):1186–1198

    CAS  Article  Google Scholar 

  20. 20.

    Rietbergen MM, Brakenhoff RH, Bloemena E, Witte BI, Snijders PJ, Heideman DA, Boon D, Koljenovic S, Baatenburg-de Jong RJ, Leemans CR (2013) Human papillomavirus detection and comorbidity: critical issues in selection of patients with oropharyngeal cancer for treatment de-escalation trials. Ann Oncol 24(11):2740–2745

    CAS  Article  Google Scholar 

  21. 21.

    Rasmussen JH, Grønhøj C, Håkansson K, Friborg J, Andersen E, Lelkaitis G, Klussmann JP, Wittekindt C, Wagner S, Vogelius IR, von Buchwald C (2019) Risk profiling based on p16 and HPV DNA more accurately predicts location of disease relapse in patients with oropharyngeal squamous cell carcinoma. Ann Oncol 30(4):629–636

    CAS  Article  Google Scholar 

  22. 22.

    Weinberger PM, Yu Z, Haffty BG, Kowalski D, Harigopal M, Brandsma J, Sasaki C, Joe J, Camp RL, Rimm DL, Psyrri A (2006) Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis. J Clin Oncol 24(5):736–747

    CAS  Article  Google Scholar 

  23. 23.

    Knipping S, Theunert A, Stock K, Wienke A (2017) Comparision of clinical versus histopathological staging in patients with oropharyngeal carcinoma. Laryngorhinootologie 96(2):104–111

    Article  Google Scholar 

  24. 24.

    Lenz M, Greess H, Baum U, Dobritz M, Kersting-Sommerhoff B (2000) Oropharynx, oral cavity, floor of the mouth: CT and MRI. Eur J Radiol 33(3):203–215

    CAS  Article  Google Scholar 

  25. 25.

    Kumar B, Cipolla MJ, Old MO, Brown NV, Kang SY, Dziegielewski PT, Durmus K, Ozer E, Agrawal A, Carrau RL, Schuller DE, Leon ME, Pan Q, Kumar P, Wood V, Burgers J, Wakely PE Jr, Teknos TN (2016) Surgical management of oropharyngeal squamous cell carcinoma: survival and functional outcomes. Head Neck 38(1):E1794–802

    Article  Google Scholar 

  26. 26.

    Samuels SE, Vainshtein J, Spector ME, Ibrahim M, McHugh JB, Tao Y, Schipper M, Worden F, Eisbruch A (2015) Impact of retropharyngeal adenopathy on distant control and survival in HPV-related oropharyngeal cancer treated with chemoradiotherapy. Radiother Oncol 116(1):75–81

    Article  Google Scholar 

  27. 27.

    Gillison ML, Zhang Q, Jordan R, Xiao W, Westra WH, Trotti A, Spencer S, Harris J, Chung CH, Ang KK (2012) Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer. j Clin Oncol 30(17):2102–2111

    CAS  Article  Google Scholar 

  28. 28.

    Habbous S, Harland LT, La Delfa A, Fadhel E, Xu W, Liu FF, Goldstein D, Waldron J, Huang SH, O’Sullivan B, Liu G (2014) Comorbidity and prognosis in head and neck cancers: differences by subsite, stage, and human papillomavirus status. Head Neck 36(6):802–810

    Article  Google Scholar 

Download references

Author information

Affiliations

  1. Klinik für Hals-Nasen-Ohrenheilkunde, Kopf- und Halschirurgie, Universitätsklinikum Freiburg, Killianstraße 5, 79106, Freiburg, Deutschland

    Dr. C. Becker, B. G. Hofauer, N. Mansour, M. C. Ketterer, T. Schulz & A. Knopf

Authors
  1. Dr. C. Becker
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. G. Hofauer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N. Mansour
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. C. Ketterer
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. T. Schulz
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. Knopf
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dr. C. Becker.

Ethics declarations

Interessenkonflikt

C. Becker, B.G. Hofauer, N. Mansour, M.C. Ketterer, T. Schulz und A. Knopf geben an, dass kein Interessenkonflikt besteht.

Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Becker, C., Hofauer, B.G., Mansour, N. et al. Die 8. Version der TNM-Klassifikation – Fluch oder Segen für das Oropharynxkarzinom?. HNO 69, 89–94 (2021). https://doi.org/10.1007/s00106-020-00875-4

Download citation

Schlüsselwörter

  • UICC
  • Humanes Papillomvirus
  • p16
  • Prognose
  • Kopf-Hals-Karzinom

Keywords

  • UICC
  • Human papillomavirus
  • p16
  • Prognosis
  • Head-neck-cancer